What's Going On With MOSY Stock And TSHA Stock?

MoSys Inc. MOSY shares are trading higher after the company announced it has expanded its patent portfolio through the purchase of five patents in the area of search and classification algorithms.

MoSys is a semiconductor company focused on the development and sale of integrated circuits for high-speed cloud networking, communications, security appliance, video, monitor and test, data center, and computing markets. 

Taysha Gene Therapies Inc TSHA shares are trading higher after the company announced the acquisition of exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of giant axonal neuropathy.

Taysha is a patient-centric gene therapy company to eradicate monogenic CNS disease. The company is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations.